Remdesivir: No magic bullet. No study in the world has shown it reduces mortality. It is to be used in moderately ill Covid patients who are hospitalised with very low oxygen and high lung damage. Mild cases improve with paracetamol, hydration and multivitamins.
Steroids: Useful in moderate to severely ill, but must be given at the right time because mortality is higher if steroids are given before a patient’s oxygen levels fall too low.
Plasma: ICMR studies have shown it’s not useful
Tocilizumab: Will be needed in less than 2% Covid patients who are severely ill and in whom steroids and anticoagulants have stopped working.
Unlock Exclusive Insights with The Tribune Premium
Take your experience further with Premium access.
Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Already a Member? Sign In Now